Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.

Oxford Instruments Healthcare, a division of Oxford Instruments that specializes in providing after-market GE computed tomography (CT) and magnetic resonance imaging (MRI) scanners, announced that it has recently received approval from the Korean Food and Drug Administration (KFDA) to import and market its refurbished GE CT equipment and parts to South Korea.

Randomized trials from the 1970s and 80s suggested that mammography screening prevents deaths from breast cancer. But the methods used by some of these studies have been criticized, and this has raised doubts about the validity of the findings. Advances in technology and treatment have also led to questions about the reliability of older trials to estimate the benefits and harms of modern day screening.

Tops Comprehensive Breast Center, Houston was a part of a recent study conducted by Stephen L. Rose, M.D., Medical Director of Tops Comprehensive Breast Center, and colleagues (Andra L. Tidwell, BSRT (R)(M); Mary F. Ice, M.D.; Amy S. Nordmann, M.D.; Russell Sexton, Jr., DO; Rui Song, M.D.) conducted exclusively at Tops, leading to advancements in screening mammography and 3-D mammography.

September 19, 2014 — Five presentations from the 2014 Breast Cancer Symposium in San Francisco earlier this month focused on new studies exploring preventive mastectomy, compliance with recommended screening mammography and risk of recurrence after pre-surgery therapy for breast cancer.

September 17, 2014 — Five-year-old Ashya King, the brain tumor patient whose case made headlines in Europe after his parents unlawfully took him from his hospital in Southampton, England, against the advice of doctors, began undergoing his prescribed treatment plan for proton therapy this week.